The 5th International Conference on Hemophilia and Rare Bleeding Disorders takes place on 10–11 October 2026 at the Grand Hyatt Hotel in Abu Dhabi, United Arab Emirates. Positioned as a premier international platform for advancing hemophilia and rare bleeding disorder care, the meeting brings together hematologists, pediatric hematologists and oncologists, internists, nurses, pharmacists and allied professionals from the UAE, the Gulf region and around the world.
The conference is chaired by Dr. Muhammad Faisal Khanani, Chief of the Division of Pediatric Hematology & Oncology at Tawam Hospital, Al Ain, with Dr. Mohammed Fahed Abdullah, Consultant in Pediatric Hematology/Oncology at Sheikh Khalifa Medical City, Abu Dhabi, as Co-Chair of the Scientific Committee. According to the organizers, the scientific committee has built a comprehensive two-day programme focused on the current challenges and clinical developments in hemophilia and rare bleeding disorders — presenting the latest advances, exchanging cutting-edge scientific knowledge and discussing new clinical applications to improve the care and treatment of patients in the UAE and the wider region.
International faculty includes Dr. Benjamin Samelson-Jones (Children's Hospital of Philadelphia, USA), Dr. Alok Srivastava (Christian Medical College, Vellore, India), Dr. Rubén Berrueco Moreno (Sant Joan de Déu Barcelona Hospital, Spain), Dr. Saad Ahmed (Children's Health Ireland at Crumlin and St. James's Hospital, Dublin), Dr. Clay Cohen (Baylor College of Medicine / Texas Children's Hospital, USA) and Ms. Marlène Beijlevelt (Amsterdam University Medical Center). Regional experts include Dr. Shahrukh Hashmi (Sheikh Shakhbout Medical City), Dr. Najam Awan, Dr. Mozah AlMarshoodi and Dr. Amar Lal (Tawam Hospital), Dr. Hadeel Saleh Mohammad and Dr. Ali Mullah-Ali (NBK Specialized Children's Hospital, Kuwait) and Dr. Anas Hamad (National Center for Cancer Care & Research, Doha).
Why attend: meet renowned experts from around the world, build networks and new partnerships, learn and share best practices, hear success stories and achievements, and learn advanced approaches to hemophilia care — from gene therapy and non-factor replacement to comprehensive care, women with bleeding disorders and the management of rare factor deficiencies.
The full two-page agenda is available as a PDF on the official website, alongside the conference brochure. A call for abstracts is linked from the website. Sponsors listed on the conference sponsors page include Sobi (Lead Sponsor), Pfizer (Diamond), Roche (Platinum), and Sanofi and Pharmalink (Gold). Fees and CME accreditation details are available on the registration page.
